The 2015 Hechtl/Lasky Symposium is April 8 at 7 p.m. in the Dana 1 Lecture Hall at Saint Anselm.
MANCHESTER, NH – Drug and alcohol abuse costs society an estimated $700 billion a year according to the National Institute on Drug Abuse, costs that go beyond the heartbreak of human suffering, impacting families, communities, businesses and state economies.
As part of an ongoing effort to bring an academic point of view to the issues important to our community, The Psychology Department of Saint Anselm College is hosting its second annual Hechtl/Lasky Symposium on April 8 at 7 p.m. in the Dana 1 Lecture Hall, 100 Saint Anselm Drive in Manchester.
Last year’s inaugural event was a screening of “The Anonymous People,” a documentary about those 23 million Americans living successfully after addiction, and the need to support others on the journey of long-term recovery.
This year, two contrasting drug abuse treatment approaches will be presented.
John Kelly, Ph.D. from Mass General Hospital/Harvard University will present his empirical research on the effectiveness of 12-step programs (e.g., Alcohol Anonymous/Narcotics Anonymous) for drug and alcohol abuse recovery. Next, Alan Budney, Ph.D., of Dartmouth College will show how behavioral therapy with contingency management is effective for treating cannabis addiction. Discussion will follow.
About the Hechtl/Lasky Symposium: This lecture series is designed to highlight the way everyday people, research excellence, and public policy can work together to make progress for those living with psychological illness. Saint Anselm professors Richard “Dick” Hechtl and Dr. Julian “Jack” Lasky, great leaders in our department, devoted their careers to promoting wellness through basic and applied psychology research. We are very proud of their contributions and legacy and are honored to remember their contributions to our community through this annual event. Please join us.
Alan Budney, Ph.D. APA President-Elect of Division 50 (Addictions)
Dr. Alan Budney is a Professor at the Geisel School of Medicine at Dartmouth. He received his PhD in Clinical Psychology from Rutgers University in 1989. He was a postdoctoral fellow and faculty member at the University of Vermont from 1990 to 2005, and then was a Professor at the University of Arkansas for Medical Sciences until he moved to Dartmouth in 2012.
Over the last 20 years he has conducted extensive research on the development and evaluation of innovative behavioral treatments for substance abuse, specializing in cannabis use disorders in adults and adolescents. His clinical research has focused on integrating abstinence-based contingency management interventions with more traditional therapies, and using computer-assisted therapies to enhance the cost effectiveness of these approaches.
He has also conducted a series of human laboratory and survey studies characterizing the cannabis withdrawal syndrome. Dr. Budney is a Fellow and past President of the Division 28 (Psychopharmacology and Substance Abuse) of the American Psychological Association, and is President-elect of Division 50 (Addictions).
He was a member of the substance use disorders working group for the development of the DSM-5, and currently serves on the Board of Directors for the College on Problems of Drug Dependence. He has served on numerous grant review committees at the NIH, was on the scientific review board of the Center for Medical Cannabis Research at the University of California San Diego, and participated regularly with the Office of National Drug Control Policy on their Marijuana and Kids Media Campaign.
Dr. Budney has been an active member of many community task forces targeting reduction in delinquency, violence, and substance abuse. Much of his research is conducted in collaboration with his wife and colleague, Dr. Catherine Stanger.
John F. Kelly, Ph.D. APA President of Division 50 (Addictions).
Dr. John Kelly is the Elizabeth R. Spallin Associate Professor of Psychiatry in Addiction Medicine at Harvard Medical School – the first endowed professorship in the field of addiction medicine at Harvard. He is also the founder and Director of the Recovery Research Institute at the Massachusetts General Hospital (MGH), the Program Director of the Addiction Recovery Management Service (ARMS) and the Associate Director of the Center for Addiction Medicine at MGH.
Dr. Kelly is President of the American Psychological Association (APA) Society of Addiction Psychology, and is also a Fellow of APA. He has served as a consultant to U.S. federal agencies such as the White House Office of National Drug Control Policy (ONDCP), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the national Institutes of Health (NIH); to non-Federal institutions, such as the Hazelden Betty Ford Foundation; and internationally to foreign governments.
He is currently an Associate Editor for the journals Addiction, and the Journal of Substance Abuse Treatment. He has published more than 100 peer-reviewed articles, reviews, and chapters in the field of addiction. His clinical and research work has focused on addiction treatment and the recovery process which has included specific research on the effectiveness of mutual-help groups, such as Alcoholics Anonymous, as adjuncts to formal care.
His additional research endeavors have focused on the translation and implementation of evidence-based practice, addiction and criminal justice, addiction treatment theories and mechanisms of action, and reducing stigma associated with addiction. He is a licensed clinical psychologist actively working with individuals and families with alcohol and other drug use disorders.
You’re one click away! Sign up for our free eNewsletter and never miss another thing